GB0015617D0 - Improved preparations for dermal delivery of active substances - Google Patents

Improved preparations for dermal delivery of active substances

Info

Publication number
GB0015617D0
GB0015617D0 GBGB0015617.4A GB0015617A GB0015617D0 GB 0015617 D0 GB0015617 D0 GB 0015617D0 GB 0015617 A GB0015617 A GB 0015617A GB 0015617 D0 GB0015617 D0 GB 0015617D0
Authority
GB
United Kingdom
Prior art keywords
formulation
active substances
therapeutic agent
unit dose
dermal delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0015617.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectura Ltd
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority to GBGB0015617.4A priority Critical patent/GB0015617D0/en
Publication of GB0015617D0 publication Critical patent/GB0015617D0/en
Priority to PL360868A priority patent/PL211890B1/pl
Priority to HU0301121A priority patent/HUP0301121A3/hu
Priority to EP01945471A priority patent/EP1296652B1/en
Priority to DK01945471T priority patent/DK1296652T3/da
Priority to US10/312,475 priority patent/US7754240B2/en
Priority to EP07122565A priority patent/EP2027851A1/en
Priority to AT01945471T priority patent/ATE429904T1/de
Priority to ES01945471T priority patent/ES2325980T3/es
Priority to AU2001267686A priority patent/AU2001267686A1/en
Priority to PCT/GB2001/002823 priority patent/WO2002000203A1/en
Priority to BR0112356-4A priority patent/BR0112356A/pt
Priority to HK03107054.5A priority patent/HK1056311B/en
Priority to DE60138547T priority patent/DE60138547D1/de
Priority to CN01811778A priority patent/CN1438878A/zh
Priority to IL15366501A priority patent/IL153665A0/xx
Priority to CA2413699A priority patent/CA2413699C/en
Priority to KR1020027017591A priority patent/KR20030041871A/ko
Priority to MXPA02012666A priority patent/MXPA02012666A/es
Priority to JP2002504985A priority patent/JP2004501185A/ja
Priority to ZA200210224A priority patent/ZA200210224B/en
Priority to NO20026171A priority patent/NO333292B1/no
Priority to AU2006202479A priority patent/AU2006202479C1/en
Priority to US12/077,331 priority patent/US20080166413A1/en
Priority to US12/832,907 priority patent/US8158613B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
GBGB0015617.4A 2000-06-26 2000-06-26 Improved preparations for dermal delivery of active substances Ceased GB0015617D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB0015617.4A GB0015617D0 (en) 2000-06-26 2000-06-26 Improved preparations for dermal delivery of active substances
JP2002504985A JP2004501185A (ja) 2000-06-26 2001-06-26 局所医薬製剤および治療法
HK03107054.5A HK1056311B (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
CN01811778A CN1438878A (zh) 2000-06-26 2001-06-26 局部用药物制剂和治疗方法
EP01945471A EP1296652B1 (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
DK01945471T DK1296652T3 (da) 2000-06-26 2001-06-26 Topiske farmaceutiske formuleringer og behandlingsfremgangsmåder
US10/312,475 US7754240B2 (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
EP07122565A EP2027851A1 (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
AT01945471T ATE429904T1 (de) 2000-06-26 2001-06-26 Topisch anwendbare arzneipräparate und verfahren zur behandlung
ES01945471T ES2325980T3 (es) 2000-06-26 2001-06-26 Formulaciones farmaceuticas topicas y metodos de tratamiento.
AU2001267686A AU2001267686A1 (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
PCT/GB2001/002823 WO2002000203A1 (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
BR0112356-4A BR0112356A (pt) 2000-06-26 2001-06-26 Formulações farmacêuticas tópicas e métodos de tratamento
PL360868A PL211890B1 (pl) 2000-06-26 2001-06-26 Formulacja farmaceutyczna do zastosowania w terapii i zastosowanie środka leczniczego do wytwarzania leku
DE60138547T DE60138547D1 (de) 2000-06-26 2001-06-26 Topisch anwendbare arzneipräparate und verfahren zur behandlung
HU0301121A HUP0301121A3 (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
IL15366501A IL153665A0 (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
CA2413699A CA2413699C (en) 2000-06-26 2001-06-26 Topical pharmaceutical formulations and methods of treatment
KR1020027017591A KR20030041871A (ko) 2000-06-26 2001-06-26 국소 약학 제제 및 치료 방법
MXPA02012666A MXPA02012666A (es) 2000-06-26 2001-06-26 Formulaciones farmaceuticas topicas y metodos de tratamiento.
ZA200210224A ZA200210224B (en) 2000-06-26 2002-12-18 Topical pharmaceutical formulations and methods of treatment.
NO20026171A NO333292B1 (no) 2000-06-26 2002-12-20 Topiske farmasoytiske formuleringer samt anvendelse av et terapeutisk middel for fremstilling av slike
AU2006202479A AU2006202479C1 (en) 2000-06-26 2006-06-09 Topical Phamaceutical Formulations and Methods of Treatment
US12/077,331 US20080166413A1 (en) 2000-06-26 2008-03-19 Topical pharmaceutical formulations and methods of treatment
US12/832,907 US8158613B2 (en) 2000-06-26 2010-07-08 Topical pharmaceutical formulations and methods of treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0015617.4A GB0015617D0 (en) 2000-06-26 2000-06-26 Improved preparations for dermal delivery of active substances

Publications (1)

Publication Number Publication Date
GB0015617D0 true GB0015617D0 (en) 2000-08-16

Family

ID=9894412

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0015617.4A Ceased GB0015617D0 (en) 2000-06-26 2000-06-26 Improved preparations for dermal delivery of active substances

Country Status (20)

Country Link
US (3) US7754240B2 (cg-RX-API-DMAC7.html)
EP (2) EP2027851A1 (cg-RX-API-DMAC7.html)
JP (1) JP2004501185A (cg-RX-API-DMAC7.html)
KR (1) KR20030041871A (cg-RX-API-DMAC7.html)
CN (1) CN1438878A (cg-RX-API-DMAC7.html)
AT (1) ATE429904T1 (cg-RX-API-DMAC7.html)
AU (2) AU2001267686A1 (cg-RX-API-DMAC7.html)
BR (1) BR0112356A (cg-RX-API-DMAC7.html)
CA (1) CA2413699C (cg-RX-API-DMAC7.html)
DE (1) DE60138547D1 (cg-RX-API-DMAC7.html)
DK (1) DK1296652T3 (cg-RX-API-DMAC7.html)
ES (1) ES2325980T3 (cg-RX-API-DMAC7.html)
GB (1) GB0015617D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0301121A3 (cg-RX-API-DMAC7.html)
IL (1) IL153665A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02012666A (cg-RX-API-DMAC7.html)
NO (1) NO333292B1 (cg-RX-API-DMAC7.html)
PL (1) PL211890B1 (cg-RX-API-DMAC7.html)
WO (1) WO2002000203A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200210224B (cg-RX-API-DMAC7.html)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188043B2 (en) * 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
GB2383950B (en) * 2002-01-11 2006-01-18 Cosmetic Warriors Ltd Cosmetic product
WO2003092784A1 (en) 2002-05-06 2003-11-13 Vectura Limited Application device for topical administration of pharmaceutical agents
EP1644004A4 (en) 2003-06-20 2010-10-06 Ronald Aung-Din LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS
US7718674B2 (en) 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
DE102004059613A1 (de) * 2004-12-10 2006-06-14 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer topischen Therapie von Neurodermitis
GB0524961D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents for systemic effect
EP1962795A1 (en) * 2005-12-07 2008-09-03 PharmaKodex Ltd Topical compositions for paediatric use
GB0524959D0 (en) * 2005-12-07 2006-01-18 Pharmakodex Ltd Topical compositions for treatment of respiratory disorders
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Research Australia Pty Ltd. gel de suspensão espumante
GB0612556D0 (en) * 2006-06-23 2006-08-02 Univ Aston Topical pharmaceutical formulations
US20090221703A1 (en) * 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US7592458B2 (en) * 2006-07-21 2009-09-22 Wright George E Dermal anesthetic compounds and pharmaceutical compositions for inducing local anesthesia and mitigating neuropathic pain
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
GB2450117A (en) * 2007-06-13 2008-12-17 Reckitt Benckiser Healthcare A water- and oxygen-occlusive blister tablet pack
EP3434264A1 (en) * 2008-07-18 2019-01-30 Biomod Concepts Inc. Microparticle for releasing an acitve agent
CA2738524C (en) 2008-10-02 2013-11-26 Mylan Inc. Method for making a multilayer adhesive laminate
AU2010265863C1 (en) 2009-06-26 2012-11-01 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
US8470304B2 (en) 2009-08-04 2013-06-25 Avidas Pharmaceuticals Llc Therapeutic vitamin D sun-protecting formulations and methods for their use
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
WO2012010238A1 (en) 2010-07-17 2012-01-26 Merck Patent Gmbh Enhancement of penetration and action
EP2543364A1 (en) * 2010-10-14 2013-01-09 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate
CN103167862A (zh) 2010-10-15 2013-06-19 宝洁公司 使用单胺氧化酶抑制剂改善上皮生物学
US8293288B2 (en) 2011-02-23 2012-10-23 Edna Ma Pain relieving composition
US8512768B2 (en) 2011-02-23 2013-08-20 Miss Smarty Pants Enterprises, Inc. Pain relieving composition
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
MX349572B (es) 2011-05-10 2017-08-03 Itochu Chemical Frontier Corp Parche no acuoso.
US10765640B2 (en) 2011-09-27 2020-09-08 Itochu Chemical Frontier Corporation Non-aqueous patch
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP2782584B1 (en) 2011-11-23 2021-06-09 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
CN102641275B (zh) * 2012-05-16 2013-04-24 江苏圣宝罗药业有限公司 复方丙酸氯倍他索与维a酸软膏剂
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
KR101768843B1 (ko) * 2013-02-28 2017-08-17 미라 파마 코포레이션 주사가능 장기-작용 국소 마취제 반고체 제형 및 이의 조성물
NZ710740A (en) 2013-02-28 2020-06-26 Dermira Inc Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
HUE072250T2 (hu) 2013-03-15 2025-11-28 Taris Biomedical Llc Gyógyszeradagoló eszközök gyógyszeráteresztõ résszel
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
ES2956840T3 (es) 2013-08-19 2023-12-29 Taris Biomedical Llc Dispositivos de administración de fármacos de múltiples unidades
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
DK3169315T3 (da) 2014-07-17 2020-08-10 Pharmaceutical Manufacturing Res Services In Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
AU2016235237B2 (en) 2015-03-23 2021-03-11 BioPharmX, Inc. Pharmaceutical tetracycline composition for dermatological use
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
CN108853140A (zh) * 2018-07-18 2018-11-23 豆立忠 一种多药物模块软膏及其制备方法
AU2019334202A1 (en) 2018-09-06 2021-03-25 Innopharmascreen, Inc. Methods and compositions for treatment of asthma or parkinson's disease
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
CN112237547B (zh) * 2020-09-28 2022-08-30 安徽美邸康药业有限公司 一种药贴成型装置
MX2020011523A (es) * 2020-10-29 2022-05-02 Exeltis Pharma Mexico S A De C V Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma.
BE1028968B1 (nl) 2020-12-29 2022-08-01 Usocore Nv Harde was zonder BHT
HU231751B1 (hu) * 2022-01-11 2026-02-28 Ödön dr. Wagner Hatóanyagát hosszabb időn keresztül csak a test hőmérsékletén leadó transzdermális készítmény és eljárás annak előállítására
JP2025532095A (ja) * 2022-09-21 2025-09-29 ザ ボード オブ トラスティス オブ ザ リーランド スタンフォード ジュニア ユニヴァーシティー 嚢胞性線維症及びその他の粘液閉塞性疾患における粘液閉塞を治療するための粘液繊毛クリアランスの相乗刺激
WO2025042298A1 (en) * 2023-08-24 2025-02-27 Douglas Pharmaceuticals Limited Pharmaceutical rectal suppository compositions of 6-thioguanine, methods of treatment and/or methods of manufacturing

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US151274A (en) * 1874-05-26 Improvement in springs for vehicles
US597849A (en) * 1898-01-25 Ditching-jack
US308343A (en) * 1884-11-25 Pail handle
US369784A (en) * 1887-09-13 fueman
US765986A (en) * 1902-06-07 1904-07-26 Nat Tube Co Conical rolls for piercing, expanding, or cross-rolling metal billets or tubular blanks.
US863941A (en) * 1906-06-05 1907-08-20 James M Robbins Wheelwright-machine.
US892890A (en) * 1907-10-14 1908-07-07 Max A Repelow Card-index.
AU513753B2 (en) * 1974-07-08 1980-12-18 Johnson & Johnson Antimicrobial composition
DE2551446B2 (de) * 1975-11-15 1977-09-15 Karl Werner Schlüter GmbH, 2000 Ham burg Verfahren zur herstellung von suppositorien
CH637014A5 (de) * 1978-09-29 1983-07-15 Sandoz Ag Verfahren zur herstellung von suppositorien.
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
US4278679A (en) * 1980-05-01 1981-07-14 Chromalloy American Corporation Combination of two or more drugs in a single dosage form wherein one of the drugs is a physostigmine compound
US4495203A (en) 1981-10-23 1985-01-22 Societe Anonyme Dite: L'oreal Anhydrous composition, stable to oxidation, based on anthralin or one of its derivatives, in a carrier consisting of a fatty acid alkyl ester and a thickener, and its use in the treatment of skin diseases
FR2515036B1 (fr) * 1981-10-23 1986-12-05 Oreal Composition stable a l'oxydation d'anthraline ou de l'un de ses derives et son utilisation dans le traitement des maladies de la peau
US4892890A (en) * 1984-11-01 1990-01-09 G. D. Searle And Company External analgesic compositions
DE3522060A1 (de) * 1985-06-20 1987-01-08 Liedtke Pharmed Gmbh Arzneipflaster fuer systemische anwendungen
DE3523454A1 (de) * 1985-07-01 1987-01-08 Eberhard Prof Dr Nuernberg Formkoerper
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
FR2633187A1 (fr) 1988-06-23 1989-12-29 Gafner Paul Felix Dispositif applicateur cutane d'une solution medicamenteuse pour le traitement dermatologique
AU622961B2 (en) * 1988-12-23 1992-04-30 Westech Industrial Ltd. Flame arrester having detonation-attenuating means
LU87416A1 (fr) * 1988-12-29 1990-07-10 Cird Microgranules charges en une substance active,constitues essentiellement d'un triglyceride d'acides gras satures et leur utilisation par voie topique dans le domaine therapeutique
US5389686A (en) * 1989-02-20 1995-02-14 Jouveinal Sa Analgesic properties of fedotozine
FR2663007A1 (fr) 1990-06-08 1991-12-13 Kodak Pathe Emballage de produits photographiques en bandes.
US5121158A (en) * 1990-10-31 1992-06-09 Umax Data System Inc. Filter driving mechanism for color optical reader
JP3086290B2 (ja) * 1991-07-26 2000-09-11 エスエス製薬株式会社 ジクロフェナクナトリウム貼付剤
JPH07258071A (ja) * 1994-03-22 1995-10-09 Ojiro Yukagaku Kenkyusho:Kk 粒状皮膚用剤およびその用途
US5597849A (en) * 1994-11-14 1997-01-28 Medical Polymer Technologies, Inc. Stick formulations for topical drug delivery of therapeutic agents and uses thereof
US5785991A (en) * 1995-06-07 1998-07-28 Alza Corporation Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
DE19524691A1 (de) * 1995-07-06 1997-01-09 Liedtke Pharmed Gmbh Methode und Zusammensetzung einer topischen Therapie von Innenohr und Labyrinth-Symptomen
US5722424A (en) * 1995-09-29 1998-03-03 Target Therapeutics, Inc. Multi-coating stainless steel guidewire
JPH09169635A (ja) * 1995-12-20 1997-06-30 Sekisui Chem Co Ltd 経皮吸収製剤
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
PT1019111E (pt) * 1998-04-27 2002-10-31 Surmodics Inc Revestimento que liberta um agente bioactivo
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6325807B1 (en) * 1999-06-11 2001-12-04 Scimed Life Systems, Inc. Variable strength sheath
US6455066B1 (en) * 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
US6517520B2 (en) * 2000-12-21 2003-02-11 Ethicon Endo Surgery, Inc. Peripherally inserted catheter with flushable guide-tube

Also Published As

Publication number Publication date
AU2001267686A1 (en) 2002-01-08
US20080166413A1 (en) 2008-07-10
HUP0301121A3 (en) 2006-07-28
NO333292B1 (no) 2013-04-29
BR0112356A (pt) 2003-05-06
PL211890B1 (pl) 2012-07-31
US7754240B2 (en) 2010-07-13
ES2325980T3 (es) 2009-09-28
CA2413699A1 (en) 2002-01-03
EP2027851A1 (en) 2009-02-25
WO2002000203A1 (en) 2002-01-03
EP1296652A1 (en) 2003-04-02
JP2004501185A (ja) 2004-01-15
IL153665A0 (en) 2003-07-06
HK1056311A1 (en) 2004-02-13
ATE429904T1 (de) 2009-05-15
US20030138503A1 (en) 2003-07-24
DK1296652T3 (da) 2009-08-17
NO20026171D0 (no) 2002-12-20
AU2006202479B2 (en) 2009-08-20
AU2006202479C1 (en) 2010-06-10
CN1438878A (zh) 2003-08-27
KR20030041871A (ko) 2003-05-27
CA2413699C (en) 2010-10-12
US8158613B2 (en) 2012-04-17
DE60138547D1 (de) 2009-06-10
MXPA02012666A (es) 2004-07-30
PL360868A1 (en) 2004-09-20
HUP0301121A2 (hu) 2003-09-29
NO20026171L (no) 2003-02-10
US20100273760A1 (en) 2010-10-28
AU2006202479A1 (en) 2006-07-06
EP1296652B1 (en) 2009-04-29
ZA200210224B (en) 2003-06-18

Similar Documents

Publication Publication Date Title
IL153665A0 (en) Topical pharmaceutical formulations and methods of treatment
GB2316004A (en) Novel formulations for transdermal delivery of pergolide
AU1079701A (en) Oral transmucosal drug dosage using solid solution
HU912442D0 (en) Process for the production of medical preparations with continuous active agent release
DE69214938D1 (de) Mittel zur topischen verabreichung von arzneiwirkstoffen
PL334348A1 (en) Method of treating prostate diseases using vitamin d formulations of retarded and/or prolonged release
PT957900E (pt) Composicoes e metodos para aplicacao topica de agentes terapeuticos
SE9703191D0 (sv) Medicament for improvement of duration of muscle function or treatment of muscle disorders or diseases
CA2186126A1 (en) Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
ATE347879T1 (de) Transdermale pharmazeutische zusammensetzung zur wirkstoffverabreichung
GEP20043216B (en) Orally Administered Controlled Drug Delivery System
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
EP0724885A4 (en) COMPOSITION ADMINISTERED BY NASAL AND PREPARATION CONTAINING THE SAME
ATE388687T1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
EP0834320A4 (en) ACTIVE COMPOSITION COMPOSED BY ALBUMIN AS AN ACTIVE INGREDIENT
AU625402B2 (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
EP0873751A3 (en) Pharmaceutical product for application to uterus mucosa
WO1999026589A3 (en) Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
SE9301877D0 (sv) In situ gel for therapeutic use
WO2001019359A3 (en) Medicaments containing pantothenic acid for the treatment of inflammatory joint disease
EP0756870A2 (en) Pharmaceutical compositions for topic use on the basis of ketoprofen
James Neuropathy: Call for info. on Voltaren Emulgel (topical diclofenac sodium)
MX9306791A (es) Suministro transdermico de cetorolac.
Lee et al. New Developments in Topical Psoriasis Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)